Anticancer Therapy SMRT-ens Up: Targeting the BCL6-SMRT Interaction in B Cell Lymphoma [PDF]
, 2010 Leigh A. Compton, Scott W. Hiebert
openalex +1 more source
BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium.
PLoS ONEAdenomyosis and leiomyomas are common benign uterine disorders characterized by abnormal cellular proliferation. The BCL6 protein, a transcriptional repressor implicated in cell proliferation and oncogenesis, has been linked to the pathogenesis of ...
Loreta Canivilo Salas +4 more
doaj +1 more source
BCL6 confers KRAS-mutant non–small-cell lung cancer resistance to BET inhibitors [PDF]
, 2021 Jiawei Guo +10 more
openalex +1 more source
Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas [PDF]
, 2020 Ella Willenbacher +5 more
openalex +1 more source
Correction to: A necrotic primary central nervous system lymphoma in immunocompetent patient with MYC and BCL6 rearrangements (double-hit lymphoma): a case report [PDF]
, 2023 openalex +1 more source
306 | CENTRAL NERVOUS SYSTEM RELAPSE IN HIGH‐GRADE B‐CELL LYMPHOMA WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS: A MULTICENTER STUDY FROM THE SPANISH GROUP GELTAMO [PDF]
Cristina García Herce +37 more
openalex +1 more source